# LLM call: summary

- Turn: 12
- Sequence: 7
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 1197
- Completion tokens: 718
- Total tokens: 1915
- Cost (USD): 0.000263

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-2898: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
Frontier autonomy and weak oversight left power/chips/sites as brakes; October open-weights spread, US election promised controls but no rules by December.

Winter shocks: ransomware crippled municipalities/hospitals, grid/ports restored first; imported robots and EU assistants cut jobs sparking protests; training power demand forced heating-vs-compute curtailments.

January US state control of labs with export licences left Europe in conditional tier, making blocked supercomputer and gigafactories existential.

EU absorption: 24h reporting, pooled telemetry, restoration grants; cohesion backstop switched to direct grants, insurer backstop, retraining vouchers — slow but stopped decline. Permitting zones and evaluation drills banked; relief local, mood humiliation.

Autumn-Spring: gigafactory halls rose but underpowered by US rationed chip/model quotas delaying Lyon/Magdeburg accelerators; councils paused grid connections amid court fight over heating guarantees. Genome paper flagged bioweapon risk as US licensed-only tailored therapies sharpened bio dependence.

Autumn delivery: US therapies arrived on licence with country quotas; EU joint procurement executed lots, binding sample-sharing and certified-assistant screening on, collapsing waiting lists where doses landed. EU assistants cut municipal/hospital backlogs by a third. Allied attribution cell contained intrusions, restoration grants prevented winter repeat; cohesion grants/vouchers paid slowly. Relief local, constraint continental; frontier gap widened as systems grew more opaque/autonomous.

February jump: US self-improving code agents designed novel battery electrolyte in weeks, unreleased and unreplicable in Europe behind export approvals, recalculating auto/utility plans and sharpening dependence.

EU patchwork continuity, no new build: extended telemetry/reporting into exercised fallback — ENISA islanding drills, paper triage, offline permitting contained March hospital intrusion where held. Councils mostly kept grid pauses pending heating-guarantee judgment; halls still underpowered; dose deliveries held waiting-list gains locally.

By autumn robots shifted from demos to mass deployment: tens of thousands of Chinese dexterous warehouse/care units with US software ordered by EU firms, triggering second displacement protests in Stuttgart/Lille/Turin outpacing retraining; Brussels offered only guidance/talks of future fund. One capital broke ranks with bilateral US hyperscaler compute-models-energy deal, contained without rupture but undermining common procurement credibility. Continuity patch held where drilled: October intrusion contained to degraded service; Commission toured therapy/assistant gains. Grid freeze at Lyon/Magdeburg persisted, halls underpowered, rumours of private teams running smuggled advanced open models; relief local, dependence now physical.


CURRENT NARRATIVE:
### The paper no one could ignore
In February a genome modelling paper circulated first as a preprint, then as recriminations. Its authors claimed a model had produced a viable design for a human-infecting organism, with methods a non-expert could follow. Critics called the methods flawed and the publication reckless at once. Inside biosecurity circles it was treated as different in kind from previous warnings, even as public coverage stayed thin.

In Brussels the timing was awkward. Hospitals were still rehearsing paper triage, town halls offline permitting, and ministers were touring wards where waiting lists had stayed down.

### A shield on repurposed money
The Commission answered with a bio detection and stockpile build run through HERA and the disease control centre: wider wastewater sequencing, clinical genomic detection, screening requirements for certified assistants handling bio-workflows, and joint procurement of broad-spectrum countermeasures. To avoid a new budget fight it repurposed unspent restoration and cohesion envelopes and carried over mandatory sample-sharing from the earlier therapy procurement.

Health ministers approved the outline by qualified majority. Lab networks welcomed the sequencing money; hospital managers noted the money was relabelled, not new.

The continuity work paid off visibly. Where islanding drills and pooled telemetry had been extended, a spring intrusion attempt against hospital networks was again held to degraded service. The Commission claimed the patch as proof that exercised fallback worked. Auditors quietly noted it worked only where drills had actually been held.

### What did not move
Elsewhere the freeze held. Grid connections at Lyon and Magdeburg stayed paused pending judgment on mayors' demands for winter heating priority over data-centre loads. The gigafactory halls stayed underpowered. Works councils in Stuttgart, Lille and Turin were offered tripartite talks linking any future automation fund to employer screening compliance — talks, not funds — while warehouse and care units kept arriving.

The capital that had cut its own hyperscaler deal stayed outside the common line despite bilateral pressure, and other buyers now openly cited it. Rumours persisted of industrial teams running advanced openly available models on undeclared capacity, with telemetry teams flagging odd bio-related workflows they could not inspect.

Relief was local again: detection kits ordered, drills rehearsed, waiting lists defended. Dependence remained physical.
```

## Raw response

```
Frontier autonomy and weak oversight left power/chips/sites as brakes; October open-weights spread, US election promised controls but no rules by December.

Winter shocks: ransomware crippled municipalities/hospitals, grid/ports restored first; imported robots and EU assistants cut jobs sparking protests; training power demand forced heating-vs-compute curtailments.

January US state control of labs with export licences left Europe in conditional tier, making blocked supercomputer and gigafactories existential.

EU absorption: 24h reporting, pooled telemetry, restoration grants; cohesion backstop to direct grants, insurer backstop, retraining vouchers — slow but stopped decline. Permitting zones and evaluation drills banked; relief local, mood humiliation.

Autumn-Spring: gigafactory halls rose but underpowered by US rationed chip/model quotas delaying Lyon/Magdeburg accelerators; councils paused grid connections amid court fight over heating guarantees. Genome paper flagged bioweapon risk as US licensed-only tailored therapies sharpened bio dependence.

Autumn delivery: US therapies arrived on licence with quotas; EU joint procurement, sample-sharing and assistant screening collapsed waiting lists where doses landed. EU assistants cut backlogs by a third. Attribution cell contained intrusions, restoration grants prevented winter repeat; cohesion grants/vouchers paid slowly. Relief local, constraint continental; frontier gap widened.

February jump: US self-improving code agents designed novel battery electrolyte in weeks, unreleased and unreplicable in Europe, recalculating auto/utility plans.

EU patchwork continuity, no new build: extended telemetry/reporting into fallback — ENISA islanding drills, paper triage, offline permitting contained March hospital intrusion where held. Grid pauses pending judgment; halls underpowered; doses held gains locally.

By autumn robots shifted to mass deployment: tens of thousands Chinese dexterous units with US software ordered, second protests in Stuttgart/Lille/Turin outpacing retraining; Brussels offered guidance/talks. One capital broke ranks with bilateral US hyperscaler deal, undermining common procurement. October intrusion contained to degraded service; grid freeze persisted, rumours of smuggled open models; dependence now physical.

February genome-modelling preprint claimed non-expert-viable human-infecting organism design — treated in biosecurity circles as different in kind. Commission answered with HERA/ECDC bio shield: wastewater sequencing, clinical genomic detection, assistant bio-workflow screening, joint broad-spectrum procurement, funded by repurposed restoration/cohesion money with mandatory sample-sharing, approved by QMV. Spring hospital intrusion again held to degraded service only where drills held. Freeze held elsewhere: Lyon/Magdeburg grid still paused, halls underpowered, automation fund still talks, breakaway hyperscaler deal cited by others, undeclared advanced open-model use with uninspectable bio workflows rumoured.
```
